Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Journal: The New England journal of medicine
Published: April 04, 2020
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 22, 2018
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: February 14, 2017
Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 16, 2015
Prevalence of hypercalcemia among cancer patients in the United States.
Journal: Cancer medicine
Published: October 02, 2015
Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment.
Journal: Biomedicines
Published: January 22, 2015
Denosumab for treatment of hypercalcemia of malignancy.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 11, 2014
Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Journal: Journal of the National Cancer Institute
Published: August 31, 2013
RE: Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.
Journal: Journal of the National Cancer Institute
Published: May 01, 2013
Last Updated: 09/26/2026